PECAM-directed delivery of catalase to endothelium protects against pulmonary vascular oxidative stress

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 285, Issue 2 29-2, 2003, Pages

  Christofidou Solomidou, Melpo ^a   Scherpereel, Arnaud ^a   Wiewrodt, Rainer ^a   Ng, Kimmie ^a   Sweitzer, Thomas ^b   Arguiri, Evguenia ^a   Shuvaev, Vladimir ^b   Solomides, Charalambos C ^c   Albelda, Steven M ^a   Muzykantov, Vladimir R ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c TEMPLE UNIVERSITY HOSPITAL   (United States)

Author keywords

Acute lung injury; Drug delivery; Platelet endothelial cell adhesion molecule

Indexed keywords

ANTIBODY; ANTIOXIDANT; CATALASE; CD31 ANTIGEN; GLUCOSE OXIDASE; HYDROGEN PEROXIDE; IMMUNOGLOBULIN G; MACROGOL; REACTIVE OXYGEN METABOLITE; THROMBOMODULIN;

ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; CONTROLLED STUDY; DRUG CONJUGATION; DRUG TARGETING; HUMAN; HUMAN CELL; IMMUNOTHERAPY; ISCHEMIA; LETHALITY; LUNG BLOOD VESSEL; LUNG ENDOTHELIUM; LUNG INJURY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; VASCULAR ENDOTHELIUM;

EID: 0042463627     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00021.2003     Document Type: Review

References (68)

1. Akerman ME, Chan WC, Laakkonen P, Bhatia SN, and Ruoslahti E. Nanocrystal targeting in vivo. Proc Natl Acad Sci USA 99: 12617-12621, 2002.
2. +. Circ Res 83: 730-737, 1998.
3. Barnard M, Baker P, and Matalon S. Mitigation of oxidant injury to lung microvasculature by intratracheal instillation of antioxidant enzymes. Am J Physiol Lung Cell Mol Physiol 265: L340-L345, 1993.
4. Cerwinka WH, Cooper D, Krieglstein CF, Ross CR, McCord JM, and Granger DN. Superoxide mediates endotoxin-induced platelet-endothelial cell adhesion in intestinal venules. Am J Physiol Heart Circ Physiol 284: H535-H541, 2003.
5. Chabot F, Mitchell JA, Gutteridge JMC, and Evans TW. Reactive oxygen species in acute lung injury. Eur Respir J 11: 745-757, 1998.
6. Christofidou-Solomidou M, Kennel S, Scherpereel A, Wiewrodt R, Solomides CC, Pietra GG, Murciano JC, Shah SA, Ischiropoulos H, Albelda SM, and Muzykantov VR. Vascular immunotargeting of glucose oxidase to the endothelial antigens induces distinct forms of oxidant acute lung injury. Am J Pathol 160: 1155-1169, 2002.
7. Christofidou-Solomidou M, Pietra GG, Solomides CC, Argiris E, Harshaw D, FitzGerald G, Albelda SM, and Muzykantov VR. Immunotargeting of glucose oxidase to endothelium in vivo causes oxidative vascular injury in the lungs. Am J Physiol Lung Cell Mol Physiol 278: L794-L805, 2000.
8. Danel C, Erzurum S, Prayssac P, Eissa M, Crystal R, Herve P, Baudet B, Mazmanian M, and Lemarchand P. Gene therapy for oxidant injury-treated diseases: adenovirus-mediated transfer of superoxide dismutase and catalase cDNAs protects against hyperoxia but not against ischemia-reperfusion lung injury. Hum Gene Ther 9: 1487-1496, 1998.
9. Danilov SM, Gavrilyuk VD, Franke FE, Pauls K, Harshaw DW, McDonald TD, Miletich DJ, and Muzykantov VR. Lung uptake of antibodies to endothelial antigens: key determinants of vascular immunotargeting. Am J Physiol Lung Cell Mol Physiol 280: L1335-L1347, 2001.
10. Davidson KG, Bersten AD, Barr HA, Dowling KD, Nicholas TE, and Doyle IR. Lung function, permeability, and surfactant composition in oleic acid-induced acute lung injury in rats. Am J Physiol Lung Cell Mol Physiol 279: L1091-L1102, 2000.
11. Eckenhoff RG, Dodia C, Tan Z, and Fisher AB. Oxygen-dependent reperfusion injury in the isolated rat lung. J Appl Physiol 72: 1454-1460, 1992.
12. Engelhardt JF. Redox-mediated gene therapies for environmental injury: approaches and concepts. Antioxid Redox Signal 1: 5-27, 1999.
13. Engelhardt JF, Sen CK, and Oberley L. Redox-modulating gene therapies for human diseases. Antioxid Redox Signal 3: 341-346, 2001.
14. Epperly MW, Travis EL, Sikora C, and Greenberger JS. Manganese [correction of Magnesium] superoxide dismutase (MnSOD) plasmid/liposome pulmonary radioprotective gene therapy: modulation of irradiation-induced mRNA for IL-1, TNF-α, and TGF-β correlates with delay of organizing alveolitis/fibrosis. Biol Blood Marrow Transplant 5: 204-214, 1999.
15. Eppihimer MJ, Russell J, Langley R, Vallien G, Anderson DC, and Granger DN. Differential expression of platelet-endothelial cell adhesion molecule-1 (PECAM-1) in murine tissues. Microcirculation 5: 179-188, 1998.
16. Eppinger MJ, Deeb GM, Bolling SF, and Ward PA. Mediators of ischemia-reperfusion injury of rat lung. Am J Pathol 150: 1773-1784, 1997.
17. Esmon CT and Owen WG. Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C. Proc Natl Acad Sci USA 78: 2249-2252, 1981.
18. Folz RJ, Abushamaa AM, and Suliman HB. Extracellular superoxide dismutase in the airways of transgenic mice reduces inflammation and attenuates lung toxicity following hyperoxia. J Clin Invest 103: 1055-1066, 1999.
19. Fox RB, Hoidal JR, Brown DM, and Repine JE. Pulmonary inflammation due to oxygen toxicity: involvement of chemotactic factors and polymorphonuclear leukocytes. Am Rev Respir Dis 123: 521-523, 1981.
20. Freeman BA and Crapo JD. Biology of disease: free radicals and tissue injury. Lab Invest 47: 412-426, 1982.
21. Fridovich I. Superoxide radical and superoxide dismutases. Annu Rev Biochem 64: 97-112, 1995.
22. Gole MD, Souza JM, Choi I, Hertkorn C, Malcolm S, Foust RF III, Finkel B, Lanken PN, and Ischiropoulos H. Plasma proteins modified by tyrosine nitration in acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol 278: L961-L967, 2000.
23. 2 and endothelial oxidative stress. Am J Physiol Lung Cell Mol Physiol 277: L271-L281, 1999.
24. Greenwald RA. Superoxide dismutase and catalase as therapeutic agents for human diseases. Free Radic Biol Med 8: 201-209, 1990.
25. Gurubhagavatula I, Amrani Y, Pratico D, Ruberg FL, Albelda SM, and Panettieri RA Jr. Engagement of human PECAM-1 (CD31) on human endothelial cells increases intracellular calcium ion concentration and stimulates prostacyclin release. J Clin Invest 101: 212-222, 1998.
26. Igarashi R, Hoshino J, Ochia A, Morizawa Y, and Mizushima Y. Lecithinized superoxide dismutase enhances its pharmacologic potency by increasing its cell membrane affinity. J Pharmacol Exp Ther 271: 1672-1677, 1994.
27. Inoue M, Ebashi I, Watanabe N, and Morino Y. Synthesis of a superoxide dismutase derivative that circulates bound to albumin and accumulates in tissues whose pH is decreased. Biochemistry 28: 6619-6624, 1989.
28. Jankov RP, Negus A, and Tanswell AK. Antioxidants as therapy in the newborn: some words of caution. Pediatr Res 50: 681-687, 2001.
29. Kennel SJ, Falcioni R, and Wesley JW. Microdistribution of specific rat monoclonal antibodies to mouse tissues and human tumor xenografts. Cancer Res 51: 1529-1536, 1991.
30. Kiely JM, Cybulsky MI, Luscinskas FW, and Gimbrone MA Jr. Immunoselective targeting of an anti-thrombin agent to the surface of cytokine-activated vascular endothelial cells. Arterioscler Thromb Vasc Biol 15: 1211-1218, 1995.
31. Langer R. Drug delivery. Drugs on target. Science 293: 58-59, 2001.
32. Lee YM, Hybertson BM, Cho HG, and Repine JE. Platelet-activating factor induces lung inflammation and leak in rats: hydrogen peroxide production along neutrophil-lung endothelial cell interfaces. J Lab Clin Med 140: 312-319, 2002.
33. Leff J, Parsons P, Day C, Taniguchi N, Jochum M, Fritz H, Moore F, Moore E, McCord J, and Repine J. Serum antioxidants as predictors of adult respiratory distress syndrome in patients with sepsis. Lancet 341: 777-780, 1993.
34. Li C and Jackson RM. Reactive species mechanisms of cellular hypoxia-reoxygenation injury. Am J Physiol Cell Physiol 282: C227-C241, 2002.
35. Li L, Crockett E, Wang DH, Galligan JJ, Fink GD, and Chen AF. Gene transfer of endothelial NO synthase and manganese superoxide dismutase on arterial vascular cell adhesion molecule-1 expression and superoxide production in deoxycorticosterone acetate-salt hypertension. Arterioscler Thromb Vasc Biol 22: 249-255, 2002.
36. Li S, Tan Y, Viroonchatapan E, Pitt BR, and Huang L. Targeted gene delivery to pulmonary endothelium by anti-PECAM antibody. Am J Physiol Lung Cell Mol Physiol 278: L504-L511, 2000.
37. Maruyama K, Kennel SJ, and Huang L. Lipid composition is important for highly efficient target binding and retention of immunoliposomes. Proc Natl Acad Sci USA 87: 5744-5748, 1990.
38. McIntosh DP, Tan XY, Oh P, and Schnitzer JE. Targeting endothelium and its dynamic caveolae for tissue-specific transcytosis in vivo: a pathway to overcome cell barriers to drug and gene delivery. Proc Natl Acad Sci USA 99: 1996-2001, 2002.
39. 2 receptors in rhesus monkeys. Am J Physiol Heart Circ Physiol 281: H1498-H1507, 2001.
40. Mulligan MS, Till GO, Smith CW, Anderson DC, Miyasaka M, Tamatani T, Todd RF III, Issekutz TB, and Ward PA. Role of leukocyte adhesion molecules in lung and dermal vascular injury after thermal trauma of skin. Am J Pathol 144: 1008-1015, 1994.
41. Murciano JC, Muro S, Koniaris L, Christofidou-Solomidou M, Harshaw D, Albelda S, Granger D, Cines D, and Muzykantov VR. ICAM-directed vascular immunotargeting of plasminogen activators to the endothelial luminal surface. Blood. In press.
42. Muro S, Wiewrodt R, Koniaris L, Albelda S, Muzykantov V, and Koval M. Antibody conjugates targeted to endothelial cell adhesion molecules are internalized via a protein kinase C-dependent pathway that resembles macropinocytosis. J Cell Sci 116: 1599-1609, 2003.
43. Muzykantov V. Immunotargeting of drugs to the pulmonary vascular endothelium as a therapeutic strategy. Pathophysiology 5: 15-33, 1998.
44. Muzykantov V, Atochina E, Ischyropoulos H, Danilov S, and Fisher A. Immunotargeting of anti-oxidant enzymes to the pulmonary endothelium. Proc Natl Acad Sci USA 93: 5213-5218, 1996.
45. Muzykantov V, Christofidou-Solomidou M, Balyasnikova I, Harshaw D, Schultz Fisher AB, and Albelda SM. Streptavidin facilitates internalization and pulmonary targeting of an anti-endothelial cell antibody (PECAM-1): a novel strategy for intraendothelial drug delivery. Proc Natl Acad Sci USA 96: 2379-2384, 1999.
46. Muzykantov V, Martynov A, Puchnina E, and Danilov S. In vivo administration of glucose oxidase conjugated with monoclonal antibody to ACE: targeting into the lung. Am Rev Respir Dis 136: 1464-1473, 1989.
47. Muzykantov VR. Targeting of superoxide dismutase and catalase to vascular endothelium. J Control Release 71: 1-21, 2001.
48. Nakada MT, Amin K, Christofidou-Solomidou M, O'Brien CD, Sun J, Gurubhagavatula I, Heavner GA, Taylor AH, Paddock C, Sun QH, Zehnder JL, Newman PJ, Albelda SM, and DeLisser HM. Antibodies against the first Ig-like domain of human platelet endothelial cell adhesion molecule-1 (PECAM-1) that inhibit PECAM-1-dependent homophilic adhesion block in vivo neutrophil recruitment. J Immunol 164: 452-462, 2000.
49. Nelson SK, Gao B, Bose S, Rizeq M, and McCord JM. A novel heparin-binding, human chimeric, superoxide dismutase improves myocardial preservation and protects from ischemiareperfusion injury. J Heart Lung Transplant 12: 1296-1303, 2002.
50. Nemzek JA, Call DR, Ebong SJ, Newcomb DE, Bolgos GL, and Remick DG. Immunopathology of a two-hit murine model of acid aspiration lung injury. Am J Physiol Lung Cell Mol Physiol 278: L512-L520, 2000.
51. Newman PJ. The biology of PECAM. J Clin Invest 99: 3-7, 1997.
52. Pittet JF, Mackersie RC, Martin TR, and Matthay MA. Biological markers of acute lung injury: prognostic and pathogenetic significance. Am J Respir Crit Care Med 155: 1187-1205, 1997.
53. Pratico D, Iuliano L, Mauriello A, Spagnoli L, Lawson JA, Mclouf J, Violi F, and FitzGerald GA. Localization of distinct F-2-isoprostanes in human atherosclerotic lesions. J Clin Invest 100: 2028-2034, 1997.
54. Predescu D, Predescu S, and Malik AB. Transport of nitrated albumin across continuous vascular endothelium. Proc Natl Acad Sci USA 99: 13932-13937, 2002.
55. Predescu SA, Predescu DN, and Palade GE. Endothelial transcytotic machinery involves supramolecular protein-lipid complexes. Mol Biol Cell 12: 1019-1033, 2001.
56. Punch J, Rees R, Cashmere B, Oldham K, Wilkins E, and Smith DJ. Acute lung injury following reperfusion after ischemia in the hind limbs of rats. J Trauma 31: 760-765, 1991.
57. Reynolds PN, Nicklin SA, Kaliberova L, Boatman BG, Grizzle WE, Balyasnikova IV, Baker AH, Danilov SM, and Curiel DT. Combined transductional and transcriptional targeting improves the specificity of transgene expression in vivo. Nat Biotechnol 19: 838-843, 2001.
58. Scherpereel A, Rome JJ, Wiewrodt R, Watkins SC, Harshaw DW, Alder S, Christofidou-Solomidou M, Haut E, Murciano JC, Nakada M, Albelda SM, and Muzykantov VR. Platelet-endothelial cell adhesion molecule-1-directed immunotargeting to cardiopulmonary vasculature. J Pharmacol Exp Ther 300: 777-786, 2002.
59. Scherpereel A, Wiewrodt R, Christofidou-Solomidou M, Gervais R, Murciano JC, Albelda SM, and Muzykantov VR. Cell-selective intracellular delivery of a foreign enzyme to endothelium in vivo using vascular immunotargeting. FASEB J 15: 416-426, 2001.
60. Shenkar R, Coulson WF, and Abraham E. Anti-transformation growth factor-β monoclonal antibodies prevent lung injury in hemorrhaged mice. Am J Respir Cell Mol Biol 11: 351-357, 1994.
61. Siflinger-Birnboim A and Malik AB. Neutrophil adhesion to endothelial cells impairs the effects of catalase and glutathione in preventing endothelial injury. J Cell Physiol 155: 234-239, 1993.
62. Sittipunt C, Steinberg KP, Ruzinski JT, Myles C, Zhu S, Goodman RB, Hudson LD, Matalon S, and Martin TR. Nitric oxide and nitrotyrosine in the lungs of patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 163: 503-510, 2001.
63. Turrens JF, Crapo JD, and Freeman BA. Protection against oxygen toxicity by intravenous injection of liposome-entrapped catalase and superoxide dismutase. J Clin Invest 73: 87-95, 1984.
64. Vujaskovic Z, Batinic-Haberle I, Rabbani ZN, Feng QF, Kang SK, Spasojevic I, Samulski TV, Fridovich I, Dewhirst MW, and Anscher MS. A small molecular weight catalytic metalloporphyrin antioxidant with superoxide dismutase (SOD) mimetic properties protects lungs from radiation-induced injury. Free Radic Biol Med 33: 857-863, 2002.
65. Ward P and Hanninghake G. Lung inflammation and fibrosis. Am J Respir Crit Care Med 157: S123-S129, 1998.
66. Warner RL, Lewis CS, Beltran L, Younkin EM, Varani J, and Johnson KJ. The role of metalloelastase in immune complex-induced acute lung injury. Am J Pathol 158: 2139-2144, 2001.
67. Wiewrodt R, Thomas AP, Cipelletti L, Christofidou-Solomidou M, Weitz DA, Feinstein SL, Schaffer D, Albelda SM, Koval M, and Muzykantov V. Size-dependent immunotargeting of cargo materials to endothelial cells via poorly internalizable surface adhesion molecules. Blood 99: 912-922, 2002.
68. Zwacka RM, Zhou W, Zhang Y, Darby CJ, Dudus L, Halldorson J, Oberley L, and Engelhardt JF. Redox gene therapy for ischemia/reperfusion injury of the liver reduces AP1 and NF-κB activation. Nat Med 4: 698-704, 1998.